Skip to content Skip to footer

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

10 articles published Follow:
AI Implementation

The Biggest Challenges to Implementing AI in Life Sciences

The promise of Artificial Intelligence (AI) in life sciences is undeniable—offering advancements in drug discovery, clinical research, and evidence generation. Yet, many organizations still struggle to implement AI effectively. To better understand these challenges, CapeStart conducted a survey of 104 life science professionals, asking them:  What are the top three barriers to success for your…

Read More

AI’s Biggest Wins

AI’s Biggest Wins: Three Core Business Areas Benefiting the Most

Across industries, businesses are turning to AI to address pressing challenges, drive innovation, and improve efficiency. According to CapeStart’s Life Science AI Research Report, organizations are increasingly identifying specific areas where AI can deliver the greatest value. By focusing on key business functions, companies aim to unlock new opportunities, streamline operations, and enhance their impact…

Read More

Pharma Manufacturing

How AI is Reshaping Pharmaceutical Manufacturing

Artificial intelligence (AI) has significantly impacted the pharmaceutical business in several ways, from drug discovery and formulation to clinical trials and monitoring for adverse drug reactions. But AI can also help improve pharma manufacturing, distribution, and supply chain management by improving efficiency, safety, quality, and other processes. Here’s how AI can be used to improve…

Read More